• Stefano Restaino, Angelo Finelli, Giulia Pellecchia, Anna Biasioli, Jessica Mauro, Carlo Ronsini, Monica Della Martina, Martina Arcieri, Luigi Della Corte, Felice Sorrentino, Lorenza Driul, and Giuseppe Vizzielli.
• Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, University-Hospital of Udine, 33100 Udine, Italy.
• Medicina (Kaunas). 2022 Jul 17; 58 (7).

AbstractBackground and Objectives: BRCA 1 and 2 mutations have a cumulative risk of developing ovarian cancer at 70 years of 41% and 15%, respectively, while a cumulative risk of breast cancer by 80 years of age was 72% for BRCA1 mutation carriers and 69% for BRCA2 mutation carriers. The NCCN recommends risk-reducing salpingo-oophorectomy (RRSO), typically between 35 and 40 years, and upon completion of childbearing in BRCA1 mutation, while it is reasonable to delay RRSO for management of ovarian cancer risk until age 40-45 years in patients with BRCA2. In recent years there have been two main lines of evolution in laparoscopy. The former concerning the development of a single-site laparoscopic and the latter concerning the miniaturisation of laparoscopic instruments (mini/micro-laparoscopy). Materials and Methods: In this case report, we show our experience in prophylactic adnexectomy, on a mutated-BRCA patient, using the MiniLap® percutaneous surgical system. Results: This type of technique is safe and effective and does not require a particular learning curve compared to single-port laparoscopy. Conclusions: The considerable aesthetic advantage of the scars, we believe, albeit to a lesser extent, is useful to find in these patients burdened by an important stress load.

24 keywords...

hide…